AMPLIFY -EXT trial of Eliquis(Apixaban)shows positive results in phase3 trial. This trial evaluated clinical and demographic predictors of all cause hospitalization in patients suffering from VTE,which include DVT and PE.DVT stands for Deep vein thrombosis and PE stands for Pulmonary embolism .
This Phase 3 trial included randomized ,double blinded,placebo controlled , extended treatment (AMPLIFY-EXT) for 12 months .
Out of 2486 total patients,138 patients were hospitalized during this AMPLIFY-EXT trial at least once.
With this 12 month extended treatment of VTE ,and its positive results provides additional support for extended anti coagulation support with Eliquis(Apixaban) in VTE patients .
BMS and Pfizer are the developers of this Eliquis drug.